Substitution of Propofol by Sevoflurane During Pediatric Cardiopulmonary Bypass (PRISKIKO)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01295190|
Recruitment Status : Completed
First Posted : February 14, 2011
Last Update Posted : May 22, 2014
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||200 participants|
|Official Title:||Substitution of Propofol by Sevoflurane During Pediatric Cardiopulmonary Bypass: Effect on Metabolic Acidosis and Clinical Outcome|
|Study Start Date :||June 2009|
|Actual Primary Completion Date :||August 2010|
|Actual Study Completion Date :||August 2010|
Patients receiving Propofol during cardiopulmonary bypass.
Patients receiving sevoflurane during cardiopulmonary bypass
- Metabolic acidosis during cardiopulmonary bypass [ Time Frame: 2 hours ]Changes of pH, base excess and lactate relative to baseline are analysed.
- Outcome parameter [ Time Frame: 1 month ]Duration of intensive care treatment and time to dismission from hospital are compared between groups.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01295190
|University Hospital Schleswig-Holstein|
|Kiel, Schleswig-Holstein, Germany, 24105|
|Principal Investigator:||Axel Fudickar, Dr.||University of Schleswig-Holstein|